## Note
nid: 1586198211870
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::MedicalArk, #AK_Step2_v11::!Shelf::#Cards_AnKing_Skipped, #AK_Step2_v11::!Shelf::IM::no_dupes, #AK_Step2_v11::!Shelf::IM::no_dupes::only_step2, #AK_Step2_v11::#B&B::01_Cardiology::Other::Perph_Vascular_Diseases, #AK_Step2_v11::#B&B::01_Cardiology::Pharm::CVS_Pharm_2, #AK_Step2_v11::#OME_banner, #AK_Step2_v11::#Resources_by_rotation::IM::amboss_medicalark, #AK_Step2_v11::#Subjects::Cardiology::12_Vascular_Pathology::Peripheral_Vascular_Pathology::CCB_Peripheral_Edema, #AK_Step2_v11::Original_decks::MedicalArk::im::amboss
markdown: false

### Text
What is the <i>management</i> for <b>calcium-channel-blocker</b>
induced <b>peripheral edema</b>?
<div>
  {{c1::ACE inhibitors or ARBs}}
</div>

### Extra
ACE inhibitors and ARBs cause preferential vasodilation of the
postcapillary blood vessels
<div>
  When used in combination with calcium channel blockers (CCB),
  this results in reduction of the transcapillary pressure and
  significantly reduces the risk of developing CCB-related
  peripheral edema
  <div>
    While the edema itself is not dangerous, it may be bothersome
    to some patients and combination therapy with an ACEI or ARB
    may have prevented this from occurring.
  </div>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_7.png"></a>
</div>

### Additional Resources


### One by one

